The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2014Pum2-mediated Translational Regulation of Alpha-synuclein mRNA Associated with Mitochondria
Objective/Rationale:
Aggregation of the protein alpha-synuclein and dysfunction of mitochondria (the powerhouse of the cell) are two critical components of Parkinson’s disease. We have... -
Research Grant, 2014Bioenergetic and Proteomic Profiling of PINK1, DJ-1 and Parkin Models
Objective/Rationale:
Some forms of familial Parkinson’s disease (PD) are due to mutations in the genes that code for the proteins PINK1, DJ-1 and parkin. These proteins have specific roles in the... -
Parkin Biology, 2014Function of Parkin-mediated Ubiquitination in Synaptic Function
Objective/Rationale:
Researchers know that the protein parkin is associated with Parkinson’s disease (PD), but need to know more about its pathways and processes to target it with... -
Parkin Biology, 2014Parkin Modulates Neuroinflammation to Sustain Dopaminergic Neuronal Health
Objective/Rationale:
People with mutations in the Parkin gene can develop young-onset Parkinson’s disease (PD). The protein parkin (genes encode proteins) modifies the structure of many other cell... -
LRRK2 Role in Idiopathic Parkinson's Disease, 2014Use of Lrrk2-associated Cellular Fingerprints to Link Familial Forms to Idiopathic Forms of Parkinson’s Disease
Objective/Rationale:
Clinical and genetic findings have established a clear link between the LRRR2 gene and Parkinson’s disease. To what extent and by what mechanisms LRRK2 contributes to... -
Research Grant, 2014Direct Reprogramming of Functional, Induced Dopaminergic Neurons from Human Adult Somatic Cells
Promising Outcomes of Original Grant:
We have established a new procedure to directly convert skin fibroblasts (a type of cell) from pre-clinical models into induced dopaminergic (iDA) neurons. We have...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.